https://stock.noler.com/us/stock/regenerex-pharma-inc https://stock.noler.com/us/stock/regenerex-pharma-inc/accounts-payable https://stock.noler.com/us/stock/regenerex-pharma-inc/accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/regenerex-pharma-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/regenerex-pharma-inc/accounts-payable-interest-bearing-current-and-noncurrent https://stock.noler.com/us/stock/regenerex-pharma-inc/accretion-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/accrued-liabilities-current https://stock.noler.com/us/stock/regenerex-pharma-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/regenerex-pharma-inc/accrued-payroll-taxes https://stock.noler.com/us/stock/regenerex-pharma-inc/accrued-payroll-taxes-current https://stock.noler.com/us/stock/regenerex-pharma-inc/accrued-professional-fees-current-and-noncurrent https://stock.noler.com/us/stock/regenerex-pharma-inc/accrued-salaries-current https://stock.noler.com/us/stock/regenerex-pharma-inc/accumulated-depreciation https://stock.noler.com/us/stock/regenerex-pharma-inc/acquisition-costs https://stock.noler.com/us/stock/regenerex-pharma-inc/additional-paid-in-capital https://stock.noler.com/us/stock/regenerex-pharma-inc/adjustment-for-amortization https://stock.noler.com/us/stock/regenerex-pharma-inc/amortization https://stock.noler.com/us/stock/regenerex-pharma-inc/amortization-of-regulatory-asset https://stock.noler.com/us/stock/regenerex-pharma-inc/aoci https://stock.noler.com/us/stock/regenerex-pharma-inc/asset-acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/regenerex-pharma-inc/asset-impairment-charges https://stock.noler.com/us/stock/regenerex-pharma-inc/basic-shares https://stock.noler.com/us/stock/regenerex-pharma-inc/business-acquisition-equity-interests-issued-or-issuable-number-of-shares-issued https://stock.noler.com/us/stock/regenerex-pharma-inc/buybacks-shares-repurchased https://stock.noler.com/us/stock/regenerex-pharma-inc/capitalized-computer-software-gross https://stock.noler.com/us/stock/regenerex-pharma-inc/cash https://stock.noler.com/us/stock/regenerex-pharma-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/regenerex-pharma-inc/cash-and-equivalents https://stock.noler.com/us/stock/regenerex-pharma-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/regenerex-pharma-inc/cash-change https://stock.noler.com/us/stock/regenerex-pharma-inc/cash-dividends https://stock.noler.com/us/stock/regenerex-pharma-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/regenerex-pharma-inc/cash-flow-breakdown https://stock.noler.com/us/stock/regenerex-pharma-inc/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/regenerex-pharma-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/regenerex-pharma-inc/commitments-and-contingencies https://stock.noler.com/us/stock/regenerex-pharma-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/regenerex-pharma-inc/common-stock-value https://stock.noler.com/us/stock/regenerex-pharma-inc/common-stock-value-outstanding https://stock.noler.com/us/stock/regenerex-pharma-inc/communication https://stock.noler.com/us/stock/regenerex-pharma-inc/comprehensive-income https://stock.noler.com/us/stock/regenerex-pharma-inc/cost-of-revenue https://stock.noler.com/us/stock/regenerex-pharma-inc/cost-of-revenue-2 https://stock.noler.com/us/stock/regenerex-pharma-inc/costs-and-expenses https://stock.noler.com/us/stock/regenerex-pharma-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/regenerex-pharma-inc/current-assets https://stock.noler.com/us/stock/regenerex-pharma-inc/current-liabilities https://stock.noler.com/us/stock/regenerex-pharma-inc/debt-annual-principal-payment https://stock.noler.com/us/stock/regenerex-pharma-inc/debt-face-amount https://stock.noler.com/us/stock/regenerex-pharma-inc/debt-increase-accrued-interest https://stock.noler.com/us/stock/regenerex-pharma-inc/debt-increase-decrease-other-net https://stock.noler.com/us/stock/regenerex-pharma-inc/debt-interest-rate https://stock.noler.com/us/stock/regenerex-pharma-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/regenerex-pharma-inc/debt-repurchase-amount https://stock.noler.com/us/stock/regenerex-pharma-inc/debt-repurchased-face-amount https://stock.noler.com/us/stock/regenerex-pharma-inc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/regenerex-pharma-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/regenerex-pharma-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/regenerex-pharma-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/regenerex-pharma-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/regenerex-pharma-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/regenerex-pharma-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/regenerex-pharma-inc/depreciation https://stock.noler.com/us/stock/regenerex-pharma-inc/depreciation-and-amortization https://stock.noler.com/us/stock/regenerex-pharma-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/development-costs https://stock.noler.com/us/stock/regenerex-pharma-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/regenerex-pharma-inc/diluted-shares https://stock.noler.com/us/stock/regenerex-pharma-inc/dilutive-shares https://stock.noler.com/us/stock/regenerex-pharma-inc/discontinued-operation-income-loss-from-discontinued-operation-net-of-tax-per-basic-share https://stock.noler.com/us/stock/regenerex-pharma-inc/due-to-related-parties-current https://stock.noler.com/us/stock/regenerex-pharma-inc/effect-of-exchange-rate-on-cash https://stock.noler.com/us/stock/regenerex-pharma-inc/effective-tax-rate https://stock.noler.com/us/stock/regenerex-pharma-inc/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/regenerex-pharma-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/regenerex-pharma-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/regenerex-pharma-inc/fees-and-commissions https://stock.noler.com/us/stock/regenerex-pharma-inc/financing-cash-flow https://stock.noler.com/us/stock/regenerex-pharma-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/regenerex-pharma-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/regenerex-pharma-inc/finite-lived-intangible-assets-translation-and-purchase-accounting-adjustments https://stock.noler.com/us/stock/regenerex-pharma-inc/foreign-currency-transaction-gain-before-tax https://stock.noler.com/us/stock/regenerex-pharma-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/regenerex-pharma-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/regenerex-pharma-inc/gain-loss-on-disposition-of-assets-1 https://stock.noler.com/us/stock/regenerex-pharma-inc/general-and-administrative-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/goodwill-translation-adjustments https://stock.noler.com/us/stock/regenerex-pharma-inc/goodwill-translation-and-purchase-accounting-adjustments https://stock.noler.com/us/stock/regenerex-pharma-inc/gross-profit https://stock.noler.com/us/stock/regenerex-pharma-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/regenerex-pharma-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/regenerex-pharma-inc/income-loss-from https://stock.noler.com/us/stock/regenerex-pharma-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/regenerex-pharma-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/regenerex-pharma-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-share https://stock.noler.com/us/stock/regenerex-pharma-inc/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/regenerex-pharma-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/regenerex-pharma-inc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/regenerex-pharma-inc/income-tax https://stock.noler.com/us/stock/regenerex-pharma-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/regenerex-pharma-inc/income-tax-examination-penalties-accrued https://stock.noler.com/us/stock/regenerex-pharma-inc/income-taxes-paid https://stock.noler.com/us/stock/regenerex-pharma-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/regenerex-pharma-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/regenerex-pharma-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/regenerex-pharma-inc/increase-decrease-in-interest-and-dividends-receivable https://stock.noler.com/us/stock/regenerex-pharma-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/regenerex-pharma-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/regenerex-pharma-inc/increase-decrease-in-materials-and-supplies https://stock.noler.com/us/stock/regenerex-pharma-inc/increase-decrease-in-notes-payable-current https://stock.noler.com/us/stock/regenerex-pharma-inc/increase-decrease-in-notes-payable-related-parties https://stock.noler.com/us/stock/regenerex-pharma-inc/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/regenerex-pharma-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/increase-decrease-in-prepaid-supplies https://stock.noler.com/us/stock/regenerex-pharma-inc/insurance-recoveries https://stock.noler.com/us/stock/regenerex-pharma-inc/insured-event-gain-loss https://stock.noler.com/us/stock/regenerex-pharma-inc/intangible-assets-current https://stock.noler.com/us/stock/regenerex-pharma-inc/intangible-assets-gross-excluding-goodwill https://stock.noler.com/us/stock/regenerex-pharma-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/regenerex-pharma-inc/interest-costs-incurred https://stock.noler.com/us/stock/regenerex-pharma-inc/interest-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/interest-expense-borrowings https://stock.noler.com/us/stock/regenerex-pharma-inc/interest-expense-on-debt https://stock.noler.com/us/stock/regenerex-pharma-inc/interest-expense-other https://stock.noler.com/us/stock/regenerex-pharma-inc/interest-expense-related-party https://stock.noler.com/us/stock/regenerex-pharma-inc/interest-paid-net https://stock.noler.com/us/stock/regenerex-pharma-inc/interest-payable https://stock.noler.com/us/stock/regenerex-pharma-inc/interest-payable-current https://stock.noler.com/us/stock/regenerex-pharma-inc/interest-revenue-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/inventory https://stock.noler.com/us/stock/regenerex-pharma-inc/inventory-write-down https://stock.noler.com/us/stock/regenerex-pharma-inc/investing-cash-flow https://stock.noler.com/us/stock/regenerex-pharma-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/regenerex-pharma-inc/lease-and-rental-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/legal-settlement-proceeds https://stock.noler.com/us/stock/regenerex-pharma-inc/lessee-finance-lease-discount-rate https://stock.noler.com/us/stock/regenerex-pharma-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/regenerex-pharma-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/regenerex-pharma-inc/long-term-debt https://stock.noler.com/us/stock/regenerex-pharma-inc/long-term-debt-fair-value https://stock.noler.com/us/stock/regenerex-pharma-inc/long-term-debt-percentage-bearing-fixed-interest-rate https://stock.noler.com/us/stock/regenerex-pharma-inc/loss-in-period https://stock.noler.com/us/stock/regenerex-pharma-inc/machinery-and-equipment-gross https://stock.noler.com/us/stock/regenerex-pharma-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/regenerex-pharma-inc/net-change-in-cash https://stock.noler.com/us/stock/regenerex-pharma-inc/net-income https://stock.noler.com/us/stock/regenerex-pharma-inc/net-income-loss-allocated-to-general-partners https://stock.noler.com/us/stock/regenerex-pharma-inc/net-income-loss-attributable-to-parent-diluted https://stock.noler.com/us/stock/regenerex-pharma-inc/net-investment-income-insurance-entity-fixed-maturities https://stock.noler.com/us/stock/regenerex-pharma-inc/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/regenerex-pharma-inc/noninterest-expense-transfer-agent-and-custodian-fees https://stock.noler.com/us/stock/regenerex-pharma-inc/notes-and-loans-payable https://stock.noler.com/us/stock/regenerex-pharma-inc/notes-payable https://stock.noler.com/us/stock/regenerex-pharma-inc/notes-payable-current https://stock.noler.com/us/stock/regenerex-pharma-inc/notes-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/regenerex-pharma-inc/number-of-operating-segments https://stock.noler.com/us/stock/regenerex-pharma-inc/number-of-reportable-segments https://stock.noler.com/us/stock/regenerex-pharma-inc/oci-before-tax-change https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-cash-flow https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-expenses https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-income https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-lease-assets https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-lease-cost https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-lease-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-lease-liability https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-lease-liability-current https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-lease-payments https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-lease-payments-due https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/regenerex-pharma-inc/operating-loss-carryforwards-valuation-allowance https://stock.noler.com/us/stock/regenerex-pharma-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/regenerex-pharma-inc/other-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/regenerex-pharma-inc/other-cost-of-operating-revenue https://stock.noler.com/us/stock/regenerex-pharma-inc/other-depreciation-and-amortization https://stock.noler.com/us/stock/regenerex-pharma-inc/other-general-and-administrative-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/other-income https://stock.noler.com/us/stock/regenerex-pharma-inc/other-income-2 https://stock.noler.com/us/stock/regenerex-pharma-inc/other-noncurrent-assets https://stock.noler.com/us/stock/regenerex-pharma-inc/other-nonoperating-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/other-notes-payable-current https://stock.noler.com/us/stock/regenerex-pharma-inc/paid-in-capital-other https://stock.noler.com/us/stock/regenerex-pharma-inc/payments-for-software https://stock.noler.com/us/stock/regenerex-pharma-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/regenerex-pharma-inc/payments-to-acquire-furniture-and-fixtures https://stock.noler.com/us/stock/regenerex-pharma-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/regenerex-pharma-inc/payments-to-acquire-machinery-and-equipment https://stock.noler.com/us/stock/regenerex-pharma-inc/payments-to-develop-software https://stock.noler.com/us/stock/regenerex-pharma-inc/preferred-shares-facts https://stock.noler.com/us/stock/regenerex-pharma-inc/preferred-stock-additional-series-par-or-stated-value-per-share https://stock.noler.com/us/stock/regenerex-pharma-inc/prepaid-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/prepaid-expense-current https://stock.noler.com/us/stock/regenerex-pharma-inc/pretax-income https://stock.noler.com/us/stock/regenerex-pharma-inc/proceeds-from-collection-of-longterm-loans-to-related-parties https://stock.noler.com/us/stock/regenerex-pharma-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/regenerex-pharma-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/regenerex-pharma-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/regenerex-pharma-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/regenerex-pharma-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/regenerex-pharma-inc/proceeds-from-repayments-of-other-debt https://stock.noler.com/us/stock/regenerex-pharma-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/regenerex-pharma-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/regenerex-pharma-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/regenerex-pharma-inc/production-costs https://stock.noler.com/us/stock/regenerex-pharma-inc/professional-and-contract-services-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/professional-fees https://stock.noler.com/us/stock/regenerex-pharma-inc/profit-loss https://stock.noler.com/us/stock/regenerex-pharma-inc/property-plant-equipment https://stock.noler.com/us/stock/regenerex-pharma-inc/public-float https://stock.noler.com/us/stock/regenerex-pharma-inc/receivable https://stock.noler.com/us/stock/regenerex-pharma-inc/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/regenerex-pharma-inc/related-party-transaction-rate https://stock.noler.com/us/stock/regenerex-pharma-inc/repayments-of-debt https://stock.noler.com/us/stock/regenerex-pharma-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/regenerex-pharma-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/regenerex-pharma-inc/repayments-of-secured-debt https://stock.noler.com/us/stock/regenerex-pharma-inc/research-and-development https://stock.noler.com/us/stock/regenerex-pharma-inc/retained-earnings https://stock.noler.com/us/stock/regenerex-pharma-inc/revenue https://stock.noler.com/us/stock/regenerex-pharma-inc/royalty-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/salaries-and-wages https://stock.noler.com/us/stock/regenerex-pharma-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/regenerex-pharma-inc/security-deposit https://stock.noler.com/us/stock/regenerex-pharma-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/sga-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/share-price https://stock.noler.com/us/stock/regenerex-pharma-inc/shareholders-equity https://stock.noler.com/us/stock/regenerex-pharma-inc/shares-authorized https://stock.noler.com/us/stock/regenerex-pharma-inc/shares-issued https://stock.noler.com/us/stock/regenerex-pharma-inc/shares-issued-2 https://stock.noler.com/us/stock/regenerex-pharma-inc/shares-issued-value-issued-for-noncash-considerations https://stock.noler.com/us/stock/regenerex-pharma-inc/shares-issued-value-other https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-award-compensation-cost https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-award-fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-based-compensation https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-granted-value-share-based-compensation https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-granted-value-share-based-compensation-gross https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-issued-shares-issued-for-stock-awards https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-issued-shares-issued-shares-purchase-of-assets https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/regenerex-pharma-inc/stock-split-ratio https://stock.noler.com/us/stock/regenerex-pharma-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/regenerex-pharma-inc/supplies https://stock.noler.com/us/stock/regenerex-pharma-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/regenerex-pharma-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/regenerex-pharma-inc/tax-rate-reconciliation-deductions https://stock.noler.com/us/stock/regenerex-pharma-inc/tax-rate-reconciliation-disposition-of-assets https://stock.noler.com/us/stock/regenerex-pharma-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/regenerex-pharma-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/regenerex-pharma-inc/tax-reconciliation-deductions https://stock.noler.com/us/stock/regenerex-pharma-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/total-accounts-payable https://stock.noler.com/us/stock/regenerex-pharma-inc/total-assets https://stock.noler.com/us/stock/regenerex-pharma-inc/total-liabilities https://stock.noler.com/us/stock/regenerex-pharma-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/regenerex-pharma-inc/translation-adjustment-functional-to-reporting-currency-increase-decrease-gross-of-tax https://stock.noler.com/us/stock/regenerex-pharma-inc/travel-and-entertainment-expense https://stock.noler.com/us/stock/regenerex-pharma-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/regenerex-pharma-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/regenerex-pharma-inc/weighted-average-number-of-share-outstanding-basic-and-diluted